# What are the Possible Outcomes of Thyroid Nodule Biopsy?

Thyroid nodule biopsy, also known as fine needle aspiration (FNA) biopsy, is a crucial diagnostic tool for evaluating thyroid nodules. The possible outcomes of a thyroid nodule biopsy can be categorized into several groups:

## Biopsy Results

### Benign
The majority of thyroid nodule biopsies (approximately 70%) yield benign results[^1]. This indicates that the nodule is non-cancerous and typically requires no further intervention unless it causes symptoms due to its size or growth[^3].

### Malignant
About 3% to 7% of thyroid biopsy results are classified as malignant[^1]. This diagnosis confirms the presence of thyroid cancer and usually necessitates surgical intervention.

### Suspicious
When a biopsy result is deemed suspicious, there is a 60% to 75% chance that the nodule is cancerous[^1]. These cases often require additional testing or surgical removal for definitive diagnosis.

### Atypia of Undetermined Significance (AUS)
This category indicates that the nodule has both benign and malignant characteristics. Approximately 5% to 15% of nodules in this category are ultimately found to be cancerous[^1].

### Follicular Neoplasm
For nodules classified as follicular neoplasms, it is challenging to determine malignancy without surgical removal. About 15% to 30% of these nodules are eventually diagnosed as cancerous[^1].

### Non-diagnostic
A non-diagnostic result occurs when there are insufficient cells in the sample to make a reliable diagnosis[^1]. This outcome is seen in about 7.2% of cases, and of these, approximately 13.4% are found to be cancerous when surgically removed[^5].

## Accuracy and Limitations

The overall accuracy of thyroid nodule biopsy is approximately 86%[^5]. However, it's important to note that false-negative results can occur. In some cases, a biopsy may come back as benign even though cancer is present, although this is rare[^4].

For nodules 4 cm or larger, the accuracy of FNA biopsy decreases significantly. Studies have shown that in these cases, up to 50% of nodules initially reported as benign on FNA were later found to be neoplastic or malignant upon surgical removal[^2].

## Additional Considerations

In cases where biopsy results are indeterminate or suspicious, additional testing such as molecular marker analysis may be recommended[^3]. These tests can help refine the diagnosis and guide treatment decisions.

It's crucial to remember that while thyroid nodule biopsy is a valuable diagnostic tool, its results should be interpreted in conjunction with other clinical factors, including ultrasound findings and patient risk factors, to determine the most appropriate management strategy.

---

## Citations
[^1]: [Cleveland Clinic: Thyroid Biopsy](https://my.clevelandclinic.org/health/diagnostics/thyroid-biopsy)  
[^2]: [PMC: FNA of Thyroid Nodules](https://pmc.ncbi.nlm.nih.gov/articles/PMC2910711/)  
[^3]: [Mount Sinai: Thyroid Nodule Evaluation](https://www.mountsinai.org/care/ent/surgery/thyroid/thyroid-nodules-diseases/evaluation)  
[^4]: [Thyroid Cancer: Thyroid Nodule FNA Biopsy](https://www.thyroidcancer.com/thyroid-nodule/fna-biopsy)  
[^5]: [Thyroid.org: Thyroid Biopsy Information](https://www.thyroid.org/patient-thyroid-information/ct-for-patients/february-2023/vol-16-issue-2-p-7-8/)  
[^6]: [Thyroid.org: FNA for Thyroid Nodules](https://www.thyroid.org/fna-thyroid-nodules/)  
[^7]: [WebMD: Thyroid Biopsy Overview](https://www.webmd.com/women/thyroid-biopsy-overview)
